Skip to content

Probiotic in ROUX_en_Y obesity surgery on gastrointestinal function and metabolic factors and weight changes

Evaluation of the effect of administering probiotic tablets after ROUX-en-Y obesity surgery on gastrointestinal function and metabolic factors and weight changes

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220702055340N1
Enrollment
134
Registered
2022-11-21
Start date
2022-07-23
Completion date
Unknown
Last updated
2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Morbid obesity. Condition 2: Bariatric surgery. Morbid (severe) obesity due to excess calories Bariatric surgery status

Interventions

Intervention 1: Intervention group: The first group received the probiotic tablets (Familact Co.) daily and started receiving medication one week after surgery until 6 months after surgery.After 4 m

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: BMI = 45 kg/m2 35 =BMI =40 kg/m2 associated with comorbidity

Exclusion criteria

Exclusion criteria: having evidence of chronic gastrointestinal, hepatic or renal disorders having evidence of chronic hepatic disorders having evidence of chronic renal disorders Pregnancy Breastfeeding in women Recieving antibiotics, probiotics or probiotic enriched foods, non-steroid anti-inflammatory drugs (NSAID) or insulin within 4 weeks before the study initiation. History of gastrointestinal surgeries

Design outcomes

Primary

MeasureTime frame
Gastrointestinal Function. Timepoint: start receiving medication 1 week after surgery and start investigation, 5week after surgery, 9weeks after surgery, 12 week after surgery then 6 month after surgery. Method of measurement: Using of Gastrointestinal Quality of Life index questionnaire.;Blood sugar. Timepoint: Before surgery and after surgery for up to 6 months. Method of measurement: Blood test.;Liver enzyme. Timepoint: Before surgery and after surgery for up to 6 months. Method of measurement: Blood test.;Triglyceride. Timepoint: Before surgery and after surgery for up to 6 months. Method of measurement: Blood test.;HbA1C. Timepoint: Before surgery and after surgery for up to 6 months. Method of measurement: Blood test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamid Melali

Esfahan University of Medical Sciences

Hamidmelali@yahoo.com+98 31 3620 2020

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026